• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中 M 和 XL 探头测量肝脏硬度的统一解读。

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.

机构信息

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Gut. 2019 Nov;68(11):2057-2064. doi: 10.1136/gutjnl-2018-317334. Epub 2019 Jan 18.

DOI:10.1136/gutjnl-2018-317334
PMID:30658997
Abstract

OBJECTIVE

The latest model of vibration-controlled transient elastography (VCTE) automatically selects M or XL probe according to patients' body built. We aim to test the application of a unified interpretation of VCTE results with probes appropriate for the body mass index (BMI) and hypothesise that this approach is not affected by hepatic steatosis.

DESIGN

We prospectively recruited 496 patients with non-alcoholic fatty liver disease who underwent VCTE by both M and XL probes within 1 week before liver biopsy.

RESULTS

391 (78.8%) and 433 (87.3%) patients had reliable liver stiffness measurement (LSM) (10 successful acquisitions and IQR:median ratio ≤0.30) by M and XL probes, respectively (p<0.001). The area under the receiver operating characteristic curves was similar between the two probes (0.75-0.88 for F2-4, 0.83-0.91 for F4). When used in the same patient, LSM by XL probe was lower than that by M probe (mean difference 2.3 kPa). In contrast, patients with BMI ≥30 kg/m had higher LSM regardless of the probe used. When M and XL probes were used in patients with BMI <30 and ≥30 kg/m, respectively, they yielded nearly identical median LSM at each fibrosis stage and similar diagnostic performance. Severe steatosis did not increase LSM or the rate of false-positive diagnosis by XL probe.

CONCLUSION

High BMI but not severe steatosis increases LSM. The same LSM cut-offs can be used without further adjustment for steatosis when M and XL probes are used according to the appropriate BMI.

摘要

目的

最新一代的控幅振动瞬时弹性成像技术(VCTE)可根据患者的体型自动选择 M 或 XL 探头。我们旨在测试根据体重指数(BMI)统一解释 VCTE 结果的应用,并假设这种方法不受肝脂肪变性的影响。

设计

我们前瞻性招募了 496 名非酒精性脂肪性肝病患者,他们在肝活检前 1 周内接受了 M 和 XL 探头的 VCTE。

结果

M 和 XL 探头分别有 391(78.8%)和 433(87.3%)例患者获得可靠的肝硬度测量值(LSM)(10 次成功采集,IQR:中位数比值≤0.30)(p<0.001)。两种探头的受试者工作特征曲线下面积相似(F2-4 为 0.75-0.88,F4 为 0.83-0.91)。在同一患者中,XL 探头的 LSM 低于 M 探头(平均差值 2.3kPa)。相反,无论使用哪种探头,BMI≥30kg/m2的患者 LSM 均较高。当 M 和 XL 探头分别用于 BMI<30kg/m2和 BMI≥30kg/m2的患者时,它们在每个纤维化阶段的中位 LSM 几乎相同,且具有相似的诊断性能。严重脂肪变性不会增加 XL 探头的 LSM 或假阳性诊断率。

结论

高 BMI 但不是严重脂肪变性会增加 LSM。当根据适当的 BMI 使用 M 和 XL 探头时,无需进一步调整脂肪变性,即可使用相同的 LSM 截断值。

相似文献

1
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中 M 和 XL 探头测量肝脏硬度的统一解读。
Gut. 2019 Nov;68(11):2057-2064. doi: 10.1136/gutjnl-2018-317334. Epub 2019 Jan 18.
2
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study.使用 FibroScan M/XL 探头测量肝脏硬度和受控衰减参数诊断非酒精性脂肪性肝病患者肝纤维化和脂肪变性的准确性:一项多中心前瞻性研究。
J Gastroenterol. 2020 Apr;55(4):428-440. doi: 10.1007/s00535-019-01635-0. Epub 2019 Oct 25.
3
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
4
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.瞬时弹性成像(fibroscan)的实用性和减重手术对病态肥胖患者非酒精性脂肪性肝病(NAFLD)的影响。
Surg Obes Relat Dis. 2018 Jan;14(1):81-91. doi: 10.1016/j.soard.2017.09.005. Epub 2017 Sep 11.
5
Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.瞬时弹性成像(FibroScan®)无创评估肝纤维化:应用 M 探头的截断值至 XL 探头。
Ann Hepatol. 2013 Jul-Aug;12(4):570-80.
6
Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.使用 XL 探头测量肝硬度和控制衰减参数在代谢相关脂肪性肝病患者中的适用性和结果,用于减重手术候选者。一项单中心观察性研究。
Obes Surg. 2021 Feb;31(2):702-711. doi: 10.1007/s11695-020-04971-w. Epub 2020 Sep 22.
7
Comparison between the M and XL probes for liver fibrosis assessment by transient elastography.通过瞬时弹性成像技术使用M探头和XL探头评估肝纤维化的比较。
Med Ultrason. 2014 Jun;16(2):119-22. doi: 10.11152/mu.201.3.2066.162.rs1is2.
8
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.使用 XL 探头测量非酒精性脂肪性肝病患者的肝硬度。
Am J Gastroenterol. 2012 Dec;107(12):1862-71. doi: 10.1038/ajg.2012.331. Epub 2012 Oct 2.
9
The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort.FibroScan M 和 XL 探头在巴西非酒精性脂肪性肝病队列中用于诊断脂肪变性和纤维化的性能。
Eur J Gastroenterol Hepatol. 2020 Feb;32(2):231-238. doi: 10.1097/MEG.0000000000001496.
10
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.FibroScan XL 探头在超重和肥胖患者肝硬度测量中的可行性和诊断性能。
Hepatology. 2012 Jan;55(1):199-208. doi: 10.1002/hep.24624. Epub 2011 Nov 18.

引用本文的文献

1
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study.全球MASH患者筛查研究倡议(GRIPonMASH)方案:一项前瞻性多中心研究的基本原理与设计
BMJ Open. 2025 May 30;15(5):e092731. doi: 10.1136/bmjopen-2024-092731.
2
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?银屑病、代谢综合征与甲氨蝶呤:这种关联是否适用于脂肪性肝病中的一个新亚类?
World J Hepatol. 2025 Apr 27;17(4):102978. doi: 10.4254/wjh.v17.i4.102978.
3
The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography.
代谢功能障碍相关脂肪性肝病的新定义:超声和弹性成像的作用
Ultrasonography. 2025 May;44(3):189-201. doi: 10.14366/usg.24219. Epub 2025 Mar 18.
4
Psoriasis and cardiovascular risk: associated and protective factors.银屑病与心血管风险:相关因素及保护因素
An Bras Dermatol. 2025 May-Jun;100(3):456-461. doi: 10.1016/j.abd.2024.07.013. Epub 2025 Mar 12.
5
Non-invasive assessment of portal hypertension: Liver stiffness and beyond.门静脉高压的非侵入性评估:肝脏硬度及其他方面。
JHEP Rep. 2024 Dec 11;7(3):101300. doi: 10.1016/j.jhepr.2024.101300. eCollection 2025 Mar.
6
Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD.血清Mac-2结合蛋白糖基化异构体作为非肥胖和肥胖型MAFLD患者纤维化生物标志物的诊断性能
Biomedicines. 2025 Feb 9;13(2):415. doi: 10.3390/biomedicines13020415.
7
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).肌肉减少性肥胖在代谢功能障碍相关脂肪性肝病(MASLD)患者中的临床相关性
Dig Dis Sci. 2025 Mar;70(3):1190-1200. doi: 10.1007/s10620-025-08844-z. Epub 2025 Jan 18.
8
Diagnostic Efficacy of Vibration-Controlled Transient Elastography in Patients With Metabolic Dysfunction-Associated Liver Disease and Chronic Hepatitis B.振动控制瞬时弹性成像技术对代谢功能障碍相关肝病和慢性乙型肝炎患者的诊断效能
Gastroenterol Res Pract. 2024 Dec 9;2024:6722810. doi: 10.1155/grp/6722810. eCollection 2024.
9
Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults.用于鉴别年轻成人代谢功能障碍相关脂肪性肝病的非侵入性指标的性能
Gut Liver. 2025 Jan 15;19(1):116-125. doi: 10.5009/gnl240323. Epub 2024 Dec 6.
10
Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study.在年轻男性中,附属骨骼肌质量与代谢功能障碍相关脂肪性肝病严重程度相关:一项横断面和纵向研究。
Hepatol Int. 2025 Feb;19(1):181-190. doi: 10.1007/s12072-024-10737-8. Epub 2024 Oct 12.